# IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHB

> **NCT03734783** · — · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 55 (actual)

## Conditions studied

- Chronic Hepatitis b

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03734783
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2019-11-15
- **Final completion:** 2019-11-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03734783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03734783, "IL-35+Breg/Il-35 Effect on T Cell Immune in Patients With CHB". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03734783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*